Skip to main content

Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?

Publication ,  Journal Article
Desjardins, A
Published in: Nat Rev Neurol
August 2015

Duke Scholars

Published In

Nat Rev Neurol

DOI

EISSN

1759-4766

Publication Date

August 2015

Volume

11

Issue

8

Start / End Page

429 / 430

Location

England

Related Subject Headings

  • Quality of Life
  • Neurology & Neurosurgery
  • Male
  • Humans
  • Glioblastoma
  • Female
  • Drug Costs
  • Dacarbazine
  • Chemoradiotherapy
  • Brain Neoplasms
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Desjardins, A. (2015). Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Nat Rev Neurol, 11(8), 429–430. https://doi.org/10.1038/nrneurol.2015.127
Desjardins, Annick. “Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?Nat Rev Neurol 11, no. 8 (August 2015): 429–30. https://doi.org/10.1038/nrneurol.2015.127.
Desjardins A. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Nat Rev Neurol. 2015 Aug;11(8):429–30.
Desjardins, Annick. “Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?Nat Rev Neurol, vol. 11, no. 8, Aug. 2015, pp. 429–30. Pubmed, doi:10.1038/nrneurol.2015.127.
Desjardins A. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Nat Rev Neurol. 2015 Aug;11(8):429–430.

Published In

Nat Rev Neurol

DOI

EISSN

1759-4766

Publication Date

August 2015

Volume

11

Issue

8

Start / End Page

429 / 430

Location

England

Related Subject Headings

  • Quality of Life
  • Neurology & Neurosurgery
  • Male
  • Humans
  • Glioblastoma
  • Female
  • Drug Costs
  • Dacarbazine
  • Chemoradiotherapy
  • Brain Neoplasms